Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
An overview of situations where market-cap weighted benchmarks are appropriate and practical tips for effective performance comparison.
28,411 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
July began with AI-driven headlines shifting attention from headlines to execution. This guide breaks down how stock ...
SpaceX's IPO is on the horizon, but you can gain exposure today through a strategic backdoor. This article explains w...
The stock market doing something unusual is shaking up how many investors think about risk and opportunity. This guid...
XLV faces a pivotal year as it tracking to beat the S&P 500 in 2026. Analysts say two factors that will decide its fa...
Two affordable small-cap stocks under $15 are drawing retail investors' attention as steady packaged foods demand and...
Warren Buffett's decades-long investing journey shows that patience and a focus on quality beat flashier moves. This ...
When a legendary investor shifts big positions, traders sit up. This piece breaks down what it could mean that billio...
Curious about a strategy that blends stock ownership with option income? This deep-dive on the JPMorgan Equity Premiu...
CDL, the VictoryShares US Large Cap High Div Volatility Wtd ETF, continues to deliver a steady income stream with cdl...
As volatility persists in 2026, a small-cap dividend ETF is drawing renewed interest from retirees seeking steady inc...
In 2026, XMAG has surged while MAGS has slipped, underscoring a shift from mega-cap AI bets to broad-market exposure....